Comparison of anti-HBs persistence after hepatitis B vaccination on two-dose schedule and three-dose schedule among adults: results from a 12-year follow up study in China

References

• WHO. [accessed 2016 06] http://apps.who.int/iris/bitstream/10665/246177/1/WHO-HIV-2016.06-eng.pdf?ua=1.
   Google Scholar
• Blumberg EA. Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices: a summary of the MMWR report. Am J Transplant. 2018;18(5):1285–1286. doi:10.1111/ajt.14763.
   PubMed Web of Science ®Google Scholar
• Cui FQ, Chinese Prevention Medicine Association; National Immunization Program, Chinese Center for Disease Control and Prevention. Technical guide for adult hepatitis B immunization in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2011;32(12):1199–1203.
   PubMedGoogle Scholar
• Liu J, Zhang S, Wang Q, Shen H, Zhang M, Zhang Y, Yan D, Liu M. Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: a population-based, cross-sectional study. Lancet Infect Dis. 2016;16(1):80–86. doi:10.1016/S1473-3099(15)00218-2.
   PubMed Web of Science ®Google Scholar
• Zhang GM, Sun XJ, Wang FZ, Zheng H, Gong XH, Miao N, Jia YX, Wu ZH, Cui FQ. Analysis of epidemiological characteristics of hepatitis B among the population of 18-59 year-old and HepB immunization strategies. Zhongguo Yi Miao He Mian Yi. 2013;19(3):266–270.
   Google Scholar
• Chlibek R, Von Sonnenburg F, Van Damme P, Smetana J, Tichy P, Gunapalaiah B, Leyssen M, Jacquet JM. Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years. J Travel Med. 2011;18(2):145–148. doi:10.1111/j.1708-8305.2010.00499.x.
   PubMed Web of Science ®Google Scholar
• Van Damme P, Leroux-Roels G, Crasta P, Messier M, Jacquet JM, Van Herck K. Antibody persistence and immune memory in adults, 15 years after a three-dose schedule of a combined hepatitis A and B vaccine. J Med Virol. 2012;84(1):11–17. doi:10.1002/jmv.22264.
   PubMed Web of Science ®Google Scholar
• Höhler T, Groeger-Bicanic G, Hoet B, Stoffel M. Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults. Vaccine. 2007;25(8):1503–1508. doi:10.1016/j.vaccine.2006.10.024.
   PubMed Web of Science ®Google Scholar
• Wu WL, Yan BY, Lyu JJ, Liu JY, Feng Y, Chen SY, Zhou LB, Liang XF, Cui FQ, Wang FZ, et al. Antibody persistence following primary vaccination with hepatitis B vaccine among normal and high-responder adults: 5-year follow-up study. Zhonghua Yu Fang Yi Xue Za Zhi. 2016;50(6):484–490. doi:10.3760/cma.j.issn.0253-9624.2016.06.003.
   PubMedGoogle Scholar
• Bruce MG, Bruden D, Hurlburt D, Zanis C, Thompson G, Rea L, Toomey M, Townshend-Bulson L, Rudolph K, Bulkow L, et al. Antibody levels and protection after hepatitis B vaccine: results of a 30-Year follow-up study and response to a booster dose. J Infect Dis. 2016;214(1):16–22. doi:10.1093/infdis/jiv748.
   PubMed Web of Science ®Google Scholar
• Van Damme P, Leroux-Roels G, Suryakiran P, Folschweiller N, Van Der Meeren O. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine. Hum Vaccin Immunother. 2017;13(5):972–980. doi:10.1080/21645515.2016.1274473.
   PubMed Web of Science ®Google Scholar
• Wang ZZ, Gao YH, Wang P, Wei L, Xie CP, Yang ZX, Lan J, Fang ZL, Zeng Y, Yan L, et al. Comparison of immunogenicity between hepatitis B vaccines with different dosages and schedules among healthy young adults in China: A 2-year follow-up study. Hum Vaccin Immunother. 2018;14(6):1475–1482. doi:10.1080/21645515.2018.1438090.
   PubMed Web of Science ®Google Scholar
• Yao J, Li J, Chen Y, Shan H, Dai XW, Yang LN, Jiang ZG, Ren JJ, Xu KJ, Ruan B, et al. The response of hepatitis B vaccination on seronegative adults with different vaccination schedules. Hum Vaccin Immunother. 2015;11(5):1102–1107. doi:10.4161/21645515.2014.985500.
   PubMed Web of Science ®Google Scholar
• Beran J, Kervyn D, Wertzova V, Hobzova L, Tichy P, Kuriyakose S, Leyssen M, Jacquet JM. Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents. Vaccine. 2010;28(37):5993–5997. doi:10.1016/j.vaccine.2010.06.104.
   PubMed Web of Science ®Google Scholar
• Beran J, Van Der Meeren O, Leyssen M, D’silva P. Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine. Vaccine. 2016;34(24):2686–2691. doi:10.1016/j.vaccine.2016.04.033.
   PubMed Web of Science ®Google Scholar
• But DY, Lai CL, Lim WL, Fung J, Wong DK, Yuen MF. Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final report. Vaccine. 2008;26(51):6587–6591. doi:10.1016/j.vaccine.2008.09.034.
   PubMed Web of Science ®Google Scholar
• Department of Mobile Population of National Health Commission of the People’s Republic of China. Report of China’s migrant population development 2017. Hai Dian, Beijing, China: China Population Publishing House; 2017.
   Google Scholar
• Greengold B, Nyamathi A, Kominski G, Wiley D, Lewis MA, Hodge F, Singer M, Spiegel B. Cost-effectiveness analysis of behavioral interventions to improve vaccination compliance in homeless adults[J]. Vaccine. 2009;27(5):718–725. doi:10.1016/j.vaccine.2008.11.031.
   PubMed Web of Science ®Google Scholar
• Norouzirad R, Shakurnia AH, Assarehzadegan MA, Serajian A, Khabazkhoob M. Serum levels of anti-hepatitis B surface antibody among vaccinated population aged 1 to 18 years in ahvaz city southwest of iran. Hepat Mon. 2014;14(1):e13625. doi:10.5812/hepatmon.13625.
   PubMed Web of Science ®Google Scholar
• Schonberger K, Riedel C, Ruckinger S, Mansmann U, Jilg W, Kries RV. Determinants of long-term protection after hepatitis B vaccination in infancy: a meta-analysis. Pediatr Infect Dis J. 2013;32(4):307–313. doi:10.1097/INF.0b013e31827bd1b0.
   PubMed Web of Science ®Google Scholar
• Baghianimoghadam MH, Shadkam MN, Hadinedoushan H. Immunity to hepatitis B vaccine among health care workers. Vaccine. 2011;29(15):2727–2729. doi:10.1016/j.vaccine.2011.01.086.
   PubMed Web of Science ®Google Scholar
• Coppola N, Corvino AR, De Pascalis S, Signoriello G, Di Fiore E, Nienhaus A, Sagnelli E, Lamberti M. Impact and long-term protection of hepatitis B vaccination:17 years after universal hepatitis B vaccination in Tunisia. Epidemiol Infect. 2016;144(16):3365–3375. doi:10.1017/S0950268816001849.
   PubMed Web of Science ®Google Scholar
• Schonberger K, Riedel C, Ruckinger S, Mansmann U, Jilg W, Kries RV. The long-term immunogenicity ofhepatitis B virus (HBV) vaccine: contributionuniversal HBV vaccination in Italy. BMC Infect Dis. 2015;15(1):1–7. doi:10.1186/s12879-014-0722-x.
   PubMedGoogle Scholar
• Zhang L, Yan BY, Li MS, Song LZ, Lü JJ, Xu Q, Xu AQ. Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China. Zhonghua Yu Fang Yi Xue Za Zhi. 2013;47(10):933–939.
   PubMedGoogle Scholar
• Gong XH, Li YH, Liu LR, Jia L, Xing YL, Wang YQ. Study on the afficacy of hepatitis B immunization among youngsters in Beijing. Zhonghua Liu Xing Bing Xue Za Zhi. 2004;25(5):388–390.
   PubMedGoogle Scholar
• Wang DH, Hu GL, Tu QF, Yu ZY, Guo SC. Study on hepatitis B virus infection and influence among children in Jiangxi Province. Zhongguo Ji Hua Mian Yi. 2004;10(10):267–270.
   Google Scholar